Japan PD-1/PD-L1 immunotherapy Market (2025-2031) Outlook | Share, Analysis, Industry, Value, Revenue, Companies, Growth, Trends, Forecast & Size

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Japan Country Macro Economic Indicators

3.2 Japan PD-1/PD-L1 immunotherapy Market Revenues & Volume, 2021 & 2031F

3.3 Japan PD-1/PD-L1 immunotherapy Market - Industry Life Cycle

3.4 Japan PD-1/PD-L1 immunotherapy Market - Porter's Five Forces

3.5 Japan PD-1/PD-L1 immunotherapy Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 Japan PD-1/PD-L1 immunotherapy Market Revenues & Volume Share, By Form, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in Japan

4.2.2 Growing adoption of immunotherapy as a treatment option

4.2.3 Favorable government regulations and policies supporting immunotherapy research and development

4.3 Market Restraints

4.3.1 High costs associated with PD-1/PD-L1 immunotherapy

4.3.2 Competition from other cancer treatment modalities

4.3.3 Limited awareness and understanding of immunotherapy among patients and healthcare providers

6.1 Japan PD-1/PD-L1 immunotherapy Market, By Type

6.1.1 Overview and Analysis

6.1.2 Japan PD-1/PD-L1 immunotherapy Market Revenues & Volume, By Type, 2018 - 2027F

6.1.3 Japan PD-1/PD-L1 immunotherapy Market Revenues & Volume, By CTLA-4 Inhibitor, 2018 - 2027F

6.1.4 Japan PD-1/PD-L1 immunotherapy Market Revenues & Volume, By PD-1 Inhibitor, 2018 - 2027F

6.1.5 Japan PD-1/PD-L1 immunotherapy Market Revenues & Volume, By PDL-1 Inhibitor, 2018 - 2027F

6.1.6 Japan PD-1/PD-L1 immunotherapy Market Revenues & Volume, By Others, 2018 - 2027F

6.2 Japan PD-1/PD-L1 immunotherapy Market, By Application

6.2.1 Overview and Analysis

6.2.2 Japan PD-1/PD-L1 immunotherapy Market Revenues & Volume, By Melanoma, 2018 - 2027F

6.2.3 Japan PD-1/PD-L1 immunotherapy Market Revenues & Volume, By Lung Cancer, 2018 - 2027F

6.2.4 Japan PD-1/PD-L1 immunotherapy Market Revenues & Volume, By Bladder Cancer, 2018 - 2027F

6.2.5 Japan PD-1/PD-L1 immunotherapy Market Revenues & Volume, By Others, 2018 - 2027F

7.1 Japan PD-1/PD-L1 immunotherapy Market Export to Major Countries

7.2 Japan PD-1/PD-L1 immunotherapy Market Imports from Major Countries

8.1 Patient response rates to PD-1/PD-L1 immunotherapy

8.2 Number of clinical trials related to PD-1/PD-L1 immunotherapy in Japan

8.3 Rate of new product launches and approvals in the PD-1/PD-L1 immunotherapy market

8.4 Percentage of oncologists prescribing PD-1/PD-L1 immunotherapy compared to other treatment options

8.5 Investment in research and development for PD-1/PD-L1 immunotherapy in Japan

9.1 Japan PD-1/PD-L1 immunotherapy Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 Japan PD-1/PD-L1 immunotherapy Market Opportunity Assessment, By Application, 2021 & 2031F

10.1 Japan PD-1/PD-L1 immunotherapy Market Revenue Share, By Companies, 2021

10.2 Japan PD-1/PD-L1 immunotherapy Market Competitive Benchmarking, By Operating and Technical Parameters